Adding genetics to health checks improves identification of people at risk for CVD

A recent study led by the University of Leicester and published in the European Heart Journal highlights the significant benefits of Genomics plc’s Integrated Risk Tool for cardiovascular disease. The findings validate how combining genetic data with traditional clinical assessments can greatly enhance early identification of individuals at risk, enabling more targeted prevention strategies.

This article was published in June 2024.